Monday 19 April 2021
Home      All news      Contact us      RSS      English
Thaipr - 11 days ago

Gan Lee receives EMA orphan drug designation for Phase I drug candidate GLR2007 for the treatment of glioma

Gan #38; Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan #38; Lee, stock code: 603087.SH), a global biopharmaceutical company, today announced that the European Medicine Agency (EMA) Committee for Orphan Medicinal Products granted orphan drug designation for the investigational compound GLR2007, for the treatment of glioma. Glioma is a broad term describing neuroepithelial tumors [ ] The post Gan Lee receives EMA orphan drug designation for Phase I drug candidate GLR2007 for the treatment of glioma appeared first on ThaiPR.NET.


Latest News
Hashtags:   

receives

 | 

orphan

 | 

designation

 | 

Phase

 | 

candidate

 | 

GLR2007

 | 

treatment

 | 

glioma

 | 

Sources